Clapham D. 2007. Calcium signaling. Cell. 131, 1047–1058.
Berridge M.J. 2016. The inositol trisphosphate/calcium signaling pathway in health and disease. Physiol. Rev. 96, 1261–1296.
Vanhaesebroeck B., Guillermet-Guibert J., Graupera M., Bilanges B. 2010. The emerging mechanisms of isoform-specific PI3K signalling. Nat. Rev. Mol. Cell Biol. 11, 329–341.
Jean S., Kiger A.A. 2014. Classes of phosphoinositide 3-kinases at a glance. J. Cell Sci. 127, 923–928.
Parys J.B., Vervliet T. 2020. New insights in the IP3 receptor and its regulation. Adv. Exp. Med. Biol. 1131, 243–270.
Graves B.M., Simerly T., Li C., Williams D.L., Wondergem R. 2012. Phosphoinositide-3-kinase/Akt-dependent signaling is required for maintenance of [Ca2+]i, ICa, and Ca2+ transients in HL-1 cardiomyocytes. J. Biomed. Sci. 19, 59.
Ghigo A., Laffargue M., Li M., Hirsch E. 2017. PI3K and calcium signaling in cardiovascular disease. Circ. Res. 121, 282–292.
Santoso N.G., Cebotaru L., Guggino W.B. 2011. Polycystin-1, 2, and STIM1 interact with IP3R to modulate ER Ca2+ release through the PI3K/Akt pathway. Cell. Physiol. Biochem. 27, 715–726.
Marchi S., Marinello M., Bononi A., Bonora M., Giorgi C., Rimessi A., Pinton P. 2012. Selective modulation of subtype III IP3R by Akt regulates ER Ca2+ release and apoptosis. Cell Death Dis. 3, e304.
Fregeau M.O., Rergimbald-Dumas Y., Guillemette G. 2011. Positive regulation of inositol 1,4,5-trisphosphate-induced Ca2+ release by mammalian target of rapamycin (mTOR) in RINm5F cells. J. Cell. Biochem. 112, 723–733.
Szado T., Vanderheyden V., Parys J.B., De Smedt H., Rietdorf K., Kotelevets L., Chastre E., Khan F., Landegren U., Söderberg O., Bootman M.D., Rode-rick H.L. 2008. Phosphorylation of inositol 1,4,5-trisphosphate receptors by protein kinase B/Akt inhibits Ca2+ release and apoptosis. Proc. Natl. Acad. Sci. USA. 105, 2427–2432.
Zhang Y., Kwon S.H., Vogel W.K., Filtz T.M. 2009. PI(3,4,5)P3 potentiates phospholipase C-β activity. J. Recept. Signal Transduct. Res. 29, 52–62.
Dymova E.A., Rogachevskaya O.A., Voronova E.A., Kotova P.D. 2021. PI828 impairs Ca2+ signaling mediated by aminergic agonists in a by a PI3-kinase independent manner. Biol. membrany (Rus.). 38 (5), 388–392.
Zhao Y., Araki S., Wu J., Teramoto T., Chang Y.-F., Nakano M., Abdelfattah A.S., Fujiwara M., Ishihara T., Nagai T., Campbell R.E. 2011. An expanded palette of genetically encoded Ca2+ indicators. Science. 333 (6051), 1888–1891.
O’Neill P.R., Gautam N. 2014. Subcellular optogenetic inhibition of G proteins generates signaling gradients and cell migration. Mol. Biol. Cell. 25 (15), 2305–2314.
Hopkins B.D., Goncalves M.D., Cantley L.C. 2020. Insulin-PI3K signaling: An evolutionarily insulated metabolic driver of cancer. Nat. Rev. Endocrinol. 16 (5), 276–283.
Backer J.M., Schroeder G.G., Kahn C.R., Myers M.G. Jr., Wilden P.A., Cahill D.A., White M.F. 1992. Insulin stimulation of phosphatidylinositol 3-kinase activity maps to insulin receptor regions required for endogenous substrate phosphorylation. J. Biol. Chem. 267 (2), 1367–1374.
留言 (0)